Wen‐Ming Chen

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

Jesús F. San Miguel, Vânia Hungria, Sung‐Soo Yoon et al. · The Lancet Oncology · 2014 · 788 citations

Medicine, Pharmacology, Pharmacotherapy +15

Scenedesmus obliquus CNW-N as a potential candidate for CO2 mitigation and biodiesel production

Shih‐Hsin Ho, Wen‐Ming Chen, Jo‐Shu Chang · Bioresource Technology · 2010 · 348 citations

Natural Sciences, Environmental Engineering, Environmental Sciences +10

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

Sonia Labeau, Elsa Afonso, Julie Benbenishty et al. · Intensive Care Medicine · 2020 · 330 citations · Full text

Medicine, Surgery, Emergency Surgery +13

Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2

Ming-De Huang, Wen‐Ming Chen, Fuzhen Qi et al. · Molecular Cancer · 2015 · 247 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential

Yuning Song, Hao Xu, Wen‐Ming Chen et al. · MedChemComm · 2014 · 232 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10